Finally, compared with other BTZ formulations, the tPA-Ald-PM-NP@BTZ achieved excellent anti-multiple myeloma efficacy in the multiple myeloma-bearing Nod-SCID mice and significantly prolonged the survival time of mice. The gene discussed is PLAT; the disease is plasma cell myeloma.